(Withdrawal) AI-Based Low-Dose 3D-DSA Reconstruction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

About this trial

If the participants agree to participate in this study, the participants will undergo two scans (classic 3D-DSA and PS-3D-DSA assisted scan) to compare the imaging effects of both. After the procedure, the investigators will record the radiation exposure and collect DSA images.

Eligibility criteria

Qualifiers

Age ≥18 years.

Requires 3D-DSA-guided interventional diagnosis or treatment (e.g., cerebral angiography, cerebral artery chemoembolization) and meets operational indications.

Can understand the study's purpose, procedures, potential risks, and benefits, and voluntarily signs a written informed consent form.

Disqualifiers

Severe heart or lung disease, such as heart failure or chronic obstructive pulmonary disease (COPD).

History of high-dose radiation exams or treatments.

Known allergies or severe adverse reactions to iodine contrast agents or other relevant medications.

Pregnant or breastfeeding women.

Trial design

Treatments tested in this trial

  • PS-3D-DSA
  • classic 3D-DSA

Treatment groups

134 Participants
are divided into 2 treatment groups

Sponsors and collaborators